Home / BusinessBusinessMarketWatchBusinessMarketWatch·Sep 14, 2026·1 min readNovo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss warsThe Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.View original source — MarketWatch ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessCNBCBusinessSep 14, 2026 · 1 minNovo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market shareCNBCHealthSouth China Morning PostHealthSep 14, 2026 · 1 minOzempic-maker Novo Nordisk slims down to ‘Novo’South China Morning PostBusinessBloombergBusinessSep 4, 2026 · 1 minNovo Owner to Build $62 Million Quantum Chip Plant in DenmarkBloombergHealthFinancial TimesHealthJun 8, 2026 · 1 minAstraZeneca advances weight-loss pill to take aim at obesity leadersFinancial Times
BusinessCNBCBusinessSep 14, 2026 · 1 minNovo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market shareCNBC
HealthSouth China Morning PostHealthSep 14, 2026 · 1 minOzempic-maker Novo Nordisk slims down to ‘Novo’South China Morning Post
BusinessBloombergBusinessSep 4, 2026 · 1 minNovo Owner to Build $62 Million Quantum Chip Plant in DenmarkBloomberg
HealthFinancial TimesHealthJun 8, 2026 · 1 minAstraZeneca advances weight-loss pill to take aim at obesity leadersFinancial Times